Imagine you stepped into the dimly lit hospital meeting room to pitch a new cancer‑diagnostic deal. You flick through slides powered by Palantir Technologies Inc.'s PLTR Foundry platform, showcasing data transparency and precision that would make legacy pharma pipelines look prehistoric.Track Palantir’s stock moves here.Down the hall, Tempus AI Inc TEM had its own room, where genomics-powered diagnostics promised to cut months off drug development timelines. Across the corridor, Recursion Pharmaceuticals In ...